Cargando…

Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003

BACKGROUND: Some Chinese herbal products (CHPs) may contain aristolochic acid (AA) or may be adulterated by the herbs suspected of containing AA which is nephrotoxic and carcinogenic. This study aims to identify the risk and the prescription profile of AA-containing CHPs (AA-CHPs) in Taiwan. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Shu-Ching, Lin, I-Hsin, Tseng, Wei-Lum, Lee, Chang-Hsing, Wang, Jung-Der
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584031/ https://www.ncbi.nlm.nih.gov/pubmed/18945373 http://dx.doi.org/10.1186/1749-8546-3-13

Ejemplares similares

Chinese herbal prescriptions for osteoarthritis in Taiwan: analysis of national health insurance dataset
por: Chen, Fang-Pey, et al.
Publicado: (2014)

Prescription profile of Chinese herbal products containing coumestrol, genestein, and/or daidzein among female users: an analysis of national health insurance data in Taiwan between 1997 and 2007
por: Wu, Chien-Tung, et al.
Publicado: (2012)

Frequency and pattern of Chinese herbal medicine prescriptions for urticaria in Taiwan during 2009: analysis of the national health insurance database
por: Chien, Pei-Shan, et al.
Publicado: (2013)

New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan
por: Chiou, Yueh-Er, et al.
Publicado: (2020)

Assessment of nephrotoxicity of herbal medicine containing aristolochic acid in mice
por: Quan, Yi, et al.
Publicado: (2020)

Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003
por: Chang, Lee-Chin, et al.
Publicado: (2008)

One-year mortality among hospital survivors of cholinesterase inhibitor poisoning based on Taiwan National Health Insurance Research Database from 2003 to 2012
por: Chuang, Min-Chun, et al.
Publicado: (2018)

Prescription of Radix Salvia miltiorrhiza in Taiwan: A Population-Based Study Using the National Health Insurance Research Database
por: Tseng, Ying-Jung, et al.
Publicado: (2021)

10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan’s National Health Insurance Research Database
por: Hsieh, Hsing-Chun, et al.
Publicado: (2017)

Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research Database
por: Ting, Chin-Tsung, et al.
Publicado: (2017)

Fungal Diseases in Taiwan—National Insurance Data and Estimation
por: Huang, Yu-Shan, et al.
Publicado: (2019)

SARS Outbreak, Taiwan, 2003
por: Hsieh, Ying-Hen, et al.
Publicado: (2004)

Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002
por: Chen, Fang-Pey, et al.
Publicado: (2011)

Population-Based Case–Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk
por: Lai, Ming-Nan, et al.
Publicado: (2010)

Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claims
por: Wang, Bih-Ru, et al.
Publicado: (2014)

Increased Risk of Urinary Tract Cancer in ESRD Patients Associated with Usage of Chinese Herbal Products Suspected of Containing Aristolochic Acid
por: Wang, Shuo-Meng, et al.
Publicado: (2014)

Reduction in the Incidence of Urological Cancers after the Ban on Chinese Herbal Products Containing Aristolochic Acid: An Interrupted Time-Series Analysis
por: Jhuang, Jing-Rong, et al.
Publicado: (2019)

High Level of Aristolochic Acid Detected With a Unique Genomic Landscape Predicts Early UTUC Onset After Renal Transplantation in Taiwan
por: Lai, Hong-Yue, et al.
Publicado: (2022)

Frequency and co-prescription pattern of Chinese herbal products for hypertension in Taiwan: a Cohort study
por: Yang, Pei-Rung, et al.
Publicado: (2015)

Health Insurance Scheme Progress Report on the Study of Cost Containment Measures for 1997
Publicado: (1996)

Core prescription pattern of Chinese herbal medicine for depressive disorders in Taiwan: a nationwide population-based study
por: Tran, Diem Ngoc Hong, et al.
Publicado: (2021)

Taiwan’s National Health Insurance Research Database: past and future
por: Hsieh, Cheng-Yang, et al.
Publicado: (2019)

Imported Cutaneous Diphtheria, Germany, 1997–2003
por: Sing, Andreas, et al.
Publicado: (2005)

Salmonella-associated Deaths, Sweden, 1997–2003
por: Ternhag, Anders, et al.
Publicado: (2006)

The Utilization of Chinese Herbal Products for Hyperthyroidism in National Health Insurance System (NHIRD) of Taiwan: A Population-Based Study
por: Chang, Cheng-Chieh, et al.
Publicado: (2022)

Willingness to pay to sustain and expand National Health Insurance services in Taiwan
por: Lang, Hui-Chu, et al.
Publicado: (2008)

Incidence of hip replacement among national health insurance enrollees in Taiwan
por: Lai, Yu-Shu, et al.
Publicado: (2008)

Antibiotic restriction policy paradoxically increased private drug consumptions outside Taiwan’s National Health Insurance
por: Kuo, Shu-Chen, et al.
Publicado: (2017)

Pharmacokinetics of p-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid Nephropathy
por: Tseng, Chiao-Shih, et al.
Publicado: (2011)

Prescription Patterns of Chinese Herbal Products for Osteoporosis in Taiwan: A Population-Based Study
por: Shih, Wei-Tai, et al.
Publicado: (2012)

Trends in pharmaceutical expenditure in the Taiwan National Health Insurance database at different hospital levels
por: Chung, Ching-Hu
Publicado: (2022)

Redistributive effects of the National Health Insurance on physicians in Taiwan: a natural experiment time series study
por: Yang, Chiang-Hsing, et al.
Publicado: (2013)

The 2003 SARS Outbreaks in Taiwan
por: Chen, Yi-Ming Arthur
Publicado: (2008)

Perceived Impact of Taiwan’s National Health Insurance Allocation Strategy: Health Professionals’ Perspective
por: Owili, Patrick Opiyo, et al.
Publicado: (2019)

An integrated system for identifying the hidden assassins in traditional medicines containing aristolochic acids
por: Wu, Lan, et al.
Publicado: (2015)

Recent developments in detoxication techniques for aristolochic acid-containing traditional Chinese medicines
por: Fan, Yang, et al.
Publicado: (2020)

Examining the types and payments of the disabilities of the insurants in the national farmers' health insurance program in Taiwan
por: Wang, Jiun-Hao, et al.
Publicado: (2010)

Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma
por: Jhuang, Jing-Rong, et al.
Publicado: (2023)

Metabolomic Analysis of Complex Chinese Remedies: Examples of Induced Nephrotoxicity in the Mouse from a Series of Remedies Containing Aristolochic Acid
por: Tsai, Dong-Ming, et al.
Publicado: (2013)

Epidemiology and risk factors for notifiable Clostridium botulinum infections in Taiwan from 2003 to 2020
por: Chen, Bao-Chung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ftvkmiru7ns4vqcs2rq6q9l5q8